TEMT is an investigational device currently under development, not available outside of NeuroEM’s clinical trials, and not available for purchase. The next TEMT clinical trial will involve treatment to mild/moderate AD patients and take place at sites within the U.S. that have not yet been determined. Please check this website or the company’s social media sites regularly for announcements regarding the upcoming clinical trial locations and when this next clinical trial will begin.

NeuroEM Therapeutics, Inc.

11811 N. Tatum Blvd.
Suite 3031
Phoenix, AZ 85028

  • This field is for validation purposes and should be left unchanged.